139 related articles for article (PubMed ID: 8062197)
1. The National Cancer Data Base report on prostate cancer.
Mettlin CJ; Murphy G
Cancer; 1994 Sep; 74(5):1640-8. PubMed ID: 8062197
[TBL] [Abstract][Full Text] [Related]
2. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut.
Polednak AP; Flannery JT
Cancer; 1992 Oct; 70(8):2152-8. PubMed ID: 1394045
[TBL] [Abstract][Full Text] [Related]
3. Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.
Latini DM; Elkin EP; Cooperberg MR; Sadetsky N; Duchane J; Carroll PR
Cancer; 2006 Feb; 106(4):789-95. PubMed ID: 16400651
[TBL] [Abstract][Full Text] [Related]
4. The National Cancer Data Base report on prostate cancer. American College of Surgeons Commission on Cancer and the American Cancer Society.
Mettlin CJ; Murphy GP; McGinnis LS; Menck HR
Cancer; 1995 Sep; 76(6):1104-12. PubMed ID: 8625214
[TBL] [Abstract][Full Text] [Related]
5. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
6. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Mettlin CJ; Murphy GP; Rosenthal DS; Menck HR
Cancer; 1998 Oct; 83(8):1679-84. PubMed ID: 9781963
[TBL] [Abstract][Full Text] [Related]
7. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment.
Mettlin CJ; Murphy GP; Cunningham MP; Menck HR
Cancer; 1997 Oct; 80(7):1261-6. PubMed ID: 9317177
[TBL] [Abstract][Full Text] [Related]
8. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States).
Morris CR; Snipes KP; Schlag R; Wright WE
Cancer Causes Control; 1999 Dec; 10(6):503-11. PubMed ID: 10616820
[TBL] [Abstract][Full Text] [Related]
10. Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993.
Mettlin C
Prostate; 1997 Aug; 32(3):221-6. PubMed ID: 9254902
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.
Hoffman RM; Harlan LC; Klabunde CN; Gilliland FD; Stephenson RA; Hunt WC; Potosky AL
J Gen Intern Med; 2003 Oct; 18(10):845-53. PubMed ID: 14521648
[TBL] [Abstract][Full Text] [Related]
12. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
13. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
[TBL] [Abstract][Full Text] [Related]
14. Marriage and ethnicity predict treatment in localized prostate carcinoma.
Denberg TD; Beaty BL; Kim FJ; Steiner JF
Cancer; 2005 May; 103(9):1819-25. PubMed ID: 15795905
[TBL] [Abstract][Full Text] [Related]
15. Ethnic differences in neuroendocrine expression in prostate cancer tissue.
Dorff TB; Liu SV; Xiong S; Cai J; Hawes D; Pinski J
Anticancer Res; 2011 Nov; 31(11):3897-901. PubMed ID: 22110216
[TBL] [Abstract][Full Text] [Related]
16. Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.
Jalloh M; Myers F; Cowan JE; Carroll PR; Cooperberg MR
Eur Urol; 2015 Mar; 67(3):451-7. PubMed ID: 24746973
[TBL] [Abstract][Full Text] [Related]
17. Contemporary risk profile of prostate cancer in the United States.
Shao YH; Demissie K; Shih W; Mehta AR; Stein MN; Roberts CB; Dipaola RS; Lu-Yao GL
J Natl Cancer Inst; 2009 Sep; 101(18):1280-3. PubMed ID: 19713548
[TBL] [Abstract][Full Text] [Related]
18. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.
Powell IJ; Bock CH; Ruterbusch JJ; Sakr W
J Urol; 2010 May; 183(5):1792-6. PubMed ID: 20299055
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
Steele CB; Li J; Huang B; Weir HK
Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
[TBL] [Abstract][Full Text] [Related]
20. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks.
Gilliland FD; Becker TM; Key CR; Samet JM
Cancer; 1994 Apr; 73(8):2192-9. PubMed ID: 8156525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
